Search Results

Displaying Results 1-2 of 2 "'MBRX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Scalable Biotech Manufacturing Unlocks a $14B Market

Mar 27, 2026, 09:15 ET Scalable Biotech Manufacturing Unlocks a $14B Market

ImmunityBio (NASDAQ: IBRX), Fate Therapeutics (NASDAQ: FATE), Fractyl Health (NASDAQ: GUTS), and Moleculin Biotech (NASDAQ: MBRX).

More news about: USA News Group

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

Oct 21, 2025, 09:20 ET Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions

their limits: Avant Technologies, Inc. (OTCQB: AVAI), Lexeo Therapeutics, Inc. (NASDAQ: LXEO), Moleculin Biotech, Inc. (NASDAQ: MBRX), Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), and Fractyl Health, Inc. (NASDAQ: GUTS).

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.